Vonoprazan
TAK-438_305
Approved small_molecule completed
Quick answer
Vonoprazan for Erosive Esophagitis is a Approved program (small_molecule) at Takeda with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Erosive Esophagitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed